Crinetics Pharmaceuticals Inc (CRNX)
56.82
+0.13
(+0.23%)
USD |
NASDAQ |
Nov 04, 16:00
56.82
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Liabilities (Quarterly): 104.77M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 104.77M |
| March 31, 2024 | 103.22M |
| December 31, 2023 | 96.25M |
| September 30, 2023 | 93.79M |
| June 30, 2023 | 39.14M |
| March 31, 2023 | 33.68M |
| December 31, 2022 | 35.85M |
| September 30, 2022 | 33.51M |
| June 30, 2022 | 35.57M |
| March 31, 2022 | 30.24M |
| December 31, 2021 | 19.07M |
| September 30, 2021 | 15.77M |
| June 30, 2021 | 15.49M |
| March 31, 2021 | 14.07M |
| Date | Value |
|---|---|
| December 31, 2020 | 14.53M |
| September 30, 2020 | 13.10M |
| June 30, 2020 | 14.35M |
| March 31, 2020 | 15.45M |
| December 31, 2019 | 13.24M |
| September 30, 2019 | 12.99M |
| June 30, 2019 | 13.05M |
| March 31, 2019 | 14.37M |
| December 31, 2018 | 11.19M |
| September 30, 2018 | 9.16M |
| June 30, 2018 | 99.88M |
| March 31, 2018 | 96.30M |
| December 31, 2017 | 30.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.10M
Minimum
Sep 2020
104.77M
Maximum
Jun 2024
39.00M
Average
30.24M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| PTC Therapeutics Inc | 2.897B |
| Zevra Therapeutics Inc | 111.93M |
| Clearside Biomedical Inc | 62.22M |
| Biomea Fusion Inc | 34.45M |
| NovaBay Pharmaceuticals Inc | 4.542M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 935.54M |
| Shareholders Equity (Quarterly) | 830.76M |
| Current Ratio | 16.09 |